TERT-BUTYL 3-HYDROXY-4-PHENYLPYRROLIDINE-1-CARBOXYLATE (RACEMIC), 95.0%, 1g

5-(Methylsulfonyl)thiophene-2-carboxylic acid, 95.0%, 500mg

[5,5'-Bis(trifluoromethyl)-2,2'-bipyridine-kappa~2~N~1~,N~1'~][bis[3,5-difluoro-2-[5-(trifluoromethyl)-2-pyridinyl-kappaN]phenyl-kappaC~1~]]iridium Hexafluorophosphate>95.0%(HPLC)(qNMR)500mg

N-(3-(DIFLUOROMETHYL)PHENYL)-N,O-DIMETHYLHYDROXYLAMINE, 95.0%, 2g

5-Hydroxypentanamide, 95+%, 250mg

n-((1h-Imidazol-2-yl)methyl)propan-2-amine, 98%, 250mg

(3'-Chloro-[1,1'-biphenyl]-2-yl)methanamine, 98%, 500mg

5-Bromonicotinic Acid>99.0%(GC)(T)25g

2-(Furan-2-yl)-2-oxoacetic acid, 95%, 5g

Colonne capillaire GC ROTI®Cap-5 HT, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

(S)-TERT-BUTYL 3-(PYRIMIDIN-4-YLOXY)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

1-Nitro-4-[(4-nitrophenyl)dithio]benzene, 97.0%, 100g

4-Hydroxybenzamidine Hydrochloride>98.0%(HPLC)(T)1g